The 5q-syndrome.

The 5q-syndrome.

Show other versions (2)

Little is known about the relationship between the 5q- syndrome and the other subtypes of MDS, primary ANLL, or therapy-related MDS and ANLL with 5q- . The natural history of these disorders is very different to the 5q- syndrome, suggesting the presence of different underlying abnormalities. In part...

Full description

Bibliographic Details
Main Authors:	Boultwood, J, Lewis, S, Wainscoat, J
Format:	Journal article
Language:	English
Published:	1994

Similar Items

5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

The 5q- syndrome.
by: Giagounidis, A, et al.
Published: (2004)

Advances in the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2010)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
by: Boultwood, J, et al.
Published: (1994)

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
by: Boultwood, J, et al.
Published: (1993)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
by: Boultwood, J, et al.
Published: (1993)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
by: Fidler, C, et al.
Published: (1999)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

Homozygous deletion of FMS in a patient with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (1990)

ISOLATION OF NOVEL CDNA CLONES MAPPING TO THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
by: Boultwood, J, et al.
Published: (1994)

Molecular analysis of the 5q-syndrome
by: Boultwood, J
Published: (2007)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (1993)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
by: Lewis, S, et al.
Published: (1995)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
by: Boultwood, J, et al.
Published: (2000)

Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene.
by: Boultwood, J, et al.
Published: (2000)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
by: Boultwood, J, et al.
Published: (2013)

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
by: Jaju, R, et al.
Published: (2000)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
by: Fidler, C, et al.
Published: (2004)

Narrowing the critical deleted region in the 5q-syndrome.
by: Jaju, R, et al.
Published: (1996)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2003)

RECENT ADVANCES IN THE 5Q- SYNDROME
by: Andrea Pellagatti, et al.
Published: (2015-05-01)

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2002)

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
by: Jaju, R, et al.
Published: (1998)

Isolation and analysis of novel candidate genes mapping to the critical region of the 5q-syndrome.
by: Boultwood, J, et al.
Published: (1999)

Molecular characterization of the 7q deletion in myeloid disorders.
by: Lewis, S, et al.
Published: (1996)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

Primary transcription map of the critical region of the 5q-syndrome.
by: Boultwood, J, et al.
Published: (1996)

Mutation analysis of the SPARC gene in the 5q-syndrome.
by: Fidler, C, et al.
Published: (2000)

Clonality in the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2001)

Lineage studies of 5q deletions using combined immunophenotyping and fish.
by: Jaju, R, et al.
Published: (1999)

Combined immunophenotyping and FISH for identification of cell lineages with the 5q-abnormality
by: Jaju, R, et al.
Published: (1999)

Molecular pathogenesis of the myelodysplastic syndromes
by: Boultwood, J, et al.
Published: (1999)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndrome.
by: Boultwood, J
Published: (2011)

Novel genes mapping to the critical region of the 5q- syndrome.
by: Boultwood, J, et al.
Published: (1997)

PHYSICAL LINKAGE OF GLUCOCORTICOID RECEPTOR (GRL) AND DOPAMINE D1 RECEPTOR (DRD1) ON THE LONG ARM OF CHROMOSOME-5
by: Boultwood, J, et al.
Published: (1991)

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS
by: Lewis, S, et al.
Published: (1993)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
by: Pellagatti, A, et al.
Published: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
by: Pellagatti, A, et al.
Published: (2005)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
by: Jadersten, M, et al.
Published: (2005)